Dr
Davide GiampiccoloProfile page
UCL Queen Square Institute of Neurology
Orcid identifier0000-0003-3849-4168
- UCL Queen Square Institute of Neurology
- University College London, Deparment of Clinical and Experimentlal Epilepsy, UCL Institute of Neurology, Victor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, WC1N 3BG, United Kingdom
BIO
Davide is a neurosurgical fellow at the National Hospital for Neurology and Neurosurgery and at the Cleveland Clinic London Hospital, and a PhD student in Clinical and Experimental Epilepsy at the Institute of Neurology at University College London (Ms. A. Miserocchi, Dr. F. Chowdhury, Prof. J.S. Duncan). He completed neurosurgical training with Prof. Francesco Sala in Italy and Prof. Hugues Duffau in France.
His work focuses on functional neuroanatomy and connectomics to improve seizure and cognitive outcome in resective surgery. He has a keen interest in direct white matter stimulation for network preservation during awake surgery. Together with Professor Duffau he recently proposed a reappraisal of current anatomical models for language function (Giampiccolo and Duffau, Brain, 2022). Together with Prof. Duncan, he provided clinical evidence that thalamostriatal disconnection during surgery supports lasting seizure-freedom (Giampiccolo et al, Brain, 2023).
His work focuses on functional neuroanatomy and connectomics to improve seizure and cognitive outcome in resective surgery. He has a keen interest in direct white matter stimulation for network preservation during awake surgery. Together with Professor Duffau he recently proposed a reappraisal of current anatomical models for language function (Giampiccolo and Duffau, Brain, 2022). Together with Prof. Duncan, he provided clinical evidence that thalamostriatal disconnection during surgery supports lasting seizure-freedom (Giampiccolo et al, Brain, 2023).
ACADEMIC POSITIONS
- Neurosurgical fellow and PhD candidateUCL Queen Square Institute of Neurology, Clinical & Experimental Epilepsy, United Kingdom25 Apr 2022 - 1 Jan 2100
SUSTAINABLE DEVELOPMENT GOALS
- 3 Good Health and Well Being